Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

Investing

Eli Lilly : LLY

All Eli Lilly Articles

688 Articles

Trey Thoelcke | Mar 13, 2014 at 8:45 AM EDT

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100

The chief strategist at Piper Jaffray released his report for March. It details how the second and third quarters typically…

Trey Thoelcke | Mar 10, 2014 at 9:05 AM EDT

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…

Trey Thoelcke | Mar 4, 2014 at 8:50 AM EST

Merrill Lynch’s Top Health Care Stocks to Buy Now

Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…

Trey Thoelcke | Feb 26, 2014 at 8:25 AM EST

Six New Stocks to Buy in the Piper Jaffray Model Portfolio

Most Wall Street firms run model portfolios for their institutional and retail clients. Here are stocks that recently were added…

Trey Thoelcke | Feb 17, 2014 at 7:05 AM EST

Biotech Buyout Bolsters Novartis Cancer Portfolio

Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not…

Jon C. Ogg | Feb 13, 2014 at 10:40 AM EST

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good…

Jon C. Ogg | Jan 23, 2014 at 10:25 AM EST

Ariad Joins Rumor Mill: Hope May Trump Reality

Ariad Pharmaceuticals could be joining the ranks of the next big biotech acquisitions. The company fits the bill of many…

Trey Thoelcke | Dec 18, 2013 at 7:00 AM EST

Teva Secures Rights to Launch Generic Viagra

ThinkstockPfizer Inc.’s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020,…

Jon C. Ogg | Nov 11, 2013 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Twitter, Best Buy, Exxon and More

Jon OggNow that we are mostly through earnings season and now that stocks have challenged all-time highs recently, investors and…

Jon C. Ogg | Nov 7, 2013 at 9:15 AM EST

Stocks to Sell or Short: The Seven Least Preferred Stocks at UBS

courtesy Deere & Co.UBS has a list of stocks that investors may want to consider selling. They could even be…

Lee Jackson | Oct 24, 2013 at 9:00 AM EDT

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

courtesy of AOL, IncHeading into the fourth quarter of this year, investors who have been long the stock market are…

Jon C. Ogg | Oct 11, 2013 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Jon OggA new earnings season has started, and stocks and bonds are dealing with a likely patch for the government…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 2, 2013 at 6:19 AM EDT

The Highest-Yielding Dividends That Are Safe to Hold

ThinkstockThe number of companies paying dividends in the S&P 500 is at a 15-year high. According to FactSet, just over…

Lee Jackson | Sep 16, 2013 at 8:45 AM EDT

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…

1 … 36 37 38 39 40 … 46

Eli Lilly : LLY

All Eli Lilly Articles

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Merrill Lynch’s Top Health Care Stocks to Buy Now

Six New Stocks to Buy in the Piper Jaffray Model Portfolio

Biotech Buyout Bolsters Novartis Cancer Portfolio

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

Ariad Joins Rumor Mill: Hope May Trump Reality

Teva Secures Rights to Launch Generic Viagra

Top Analyst Upgrades and Downgrades: Twitter, Best Buy, Exxon and More

Stocks to Sell or Short: The Seven Least Preferred Stocks at UBS

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

The Highest-Yielding Dividends That Are Safe to Hold

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Live: Will Intuit’s Q4 Earnings Tonight Extend the Stock’s 25% Rebound?

Wall Street Just Invented the ‘Neocloud’ ETF. It Owns the Companies Renting AI Compute to Everyone Else

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here’s What a Plan Looks Like.

Google’s Wins Make Founders Brin And Page $50 Billion Richer

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

Clark Howard Warned Apple Traps You in Forever Leases and Now Three New Macs Just Landed

Microsoft Just Ripped 28% in a Month. What Would It Take to Get MSFT Stock Up to $600?

Wall Street Just Invented the ‘Neocloud’ ETF. It Owns the Companies Renting AI Compute to Everyone Else

Eli Lilly : LLY

All Eli Lilly Articles

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Merrill Lynch’s Top Health Care Stocks to Buy Now

Six New Stocks to Buy in the Piper Jaffray Model Portfolio

Biotech Buyout Bolsters Novartis Cancer Portfolio

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

Ariad Joins Rumor Mill: Hope May Trump Reality

Teva Secures Rights to Launch Generic Viagra

Top Analyst Upgrades and Downgrades: Twitter, Best Buy, Exxon and More

Stocks to Sell or Short: The Seven Least Preferred Stocks at UBS

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

The Highest-Yielding Dividends That Are Safe to Hold

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Live: Will Intuit’s Q4 Earnings Tonight Extend the Stock’s 25% Rebound?

Wall Street Just Invented the ‘Neocloud’ ETF. It Owns the Companies Renting AI Compute to Everyone Else

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here’s What a Plan Looks Like.

Google’s Wins Make Founders Brin And Page $50 Billion Richer

Featured Reads

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

Clark Howard Warned Apple Traps You in Forever Leases and Now Three New Macs Just Landed